| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |